Adarx Pharmaceuticals
- Market cap
- 1.77B
- P/E (TTM)i
- -20.15
- P/Bi
- -7.06
- EPSi
- -0.97
- Div yieldi
- 0.00%
- 52W posi
- 2%
Anonymous reader poll. Unscientific, not investment advice.
Adarx Pharmaceuticals shares were changing hands at 17.33, down 6.73% on the day. The company carries a market value of roughly 1.77B, the #2823 most valuable US-listed company we track. Against a 52-week band of 17.20-23.21, the shares are currently 2% of the way up.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 year.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Key statistics
Price & volume
- Prev close
- 18.58
- Open
- 18.33
- Day range
- 17.20 - 18.70
- Avg price
- 17.93
- Volume
- 705.70K
- Turnover
- 12.65M
- Turnover ratei
- 3.23%
- Volume ratioi
- 0.76
- Amplitudei
- 8.07%
- 52-week rangei
- 17.20 - 23.21
Valuation
- P/Ei
- -17.87
- P/E (TTM)i
- -20.15
- P/Bi
- -7.06
- EPSi
- -0.97
- Book value / shi
- -2.46
- Net profit
- -99.13M
- Net assets
- -251.01M
Share structure
- Market cap
- 1.77B
- Float capi
- 379.09M
- Shares out
- 102.20M
- Float sharesi
- 21.88M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2026-09-25
25.3% below the 52-week high
Trading activity
Net capital flow main funds, last 7 sessions
-539.13K net over the window
Frequently asked questions
What is the current stock price of Adarx Pharmaceuticals (ADRX)?
Adarx Pharmaceuticals last traded at 17.33. The quote on this page refreshes every few seconds while US markets are open.
What is Adarx Pharmaceuticals's market cap?
About 1.77B.
What is the P/E ratio of Adarx Pharmaceuticals?
The trailing twelve-month P/E is -20.15. The Valuation tab shows it against the stock's own five-year range.
Does Adarx Pharmaceuticals pay a dividend?
Adarx Pharmaceuticals does not currently pay a regular dividend.
What is Adarx Pharmaceuticals's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Adarx Pharmaceuticals a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-10-08 02:52:33 · For reference only, not investment advice and not tailored to your situation.